AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01283737 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Mosaicplasty
Description: Mosaicplasty procedure performed to treat OCD of the knee
Study NCT05435521 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Personalized multicomponent exercise program (strength, resistance, balance, and flexibility) (PMEP)
Description: Physical activity expert will design for each participant a personalized exercise program according to baseline situation and previous physical activity. Both will be measured prior to initiation of activity program. Each participant is free to perform physical activity program at his house, outdoor or in a gym as long as it fulfills the prespecified requirements. Exercise programs will be acquired a more personalized shape during the course of the study.~In order to motivate participants, personal motivational messages will be sent each week through mail contact or using WhatsApp Social Media.~Physical activity will be registered in an activity wristband delivered to each participant at baseline evaluation.
Study NCT05435521 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Personalized multicomponent exercise program (strength, resistance, balance, and flexibility) (PMEP)
Description: Physical activity expert will design for each participant a personalized exercise program according to baseline situation and previous physical activity. Both will be measured prior to initiation of activity program. Each participant is free to perform physical activity program at his house, outdoor or in a gym as long as it fulfills the prespecified requirements. Exercise programs will be acquired a more personalized shape during the course of the study.~In order to motivate participants, personal motivational messages will be sent each week through mail contact or using WhatsApp Social Media.~Physical activity will be registered in an activity wristband delivered to each participant at baseline evaluation.
Study NCT05428618 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: e-BariS app group
Description: During the discharge process, informed consent will be obtained from the patients and the measurement tools will be filled and the mobile application will be downloaded to their phones. The intervention group will have access to all the content of the mobile application, which includes the Self-Monitoring Module and the Patient Education Module. Passwords will be defined so that patients in the intervention group can access the Patient Education Module. Information on the introduction and use of the application will be presented to the patient by the researcher.~The patients will be followed for six months within the scope of the project. In addition, reminder notifications will be sent to patients via the mobile application in line with the areas that patients can access. At one, three, and six months after surgery, he will complete other assessment scales during outpatient follow-up. For patients providing remote control, the scale will be sent online.
Study NCT05428618 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Self-Monitoring Group
Description: Patients in the control group will only have access to the Self-Monitoring Module in the application. Other fields will be encrypted. Patients in the control group will also be informed about the area they can access. Patients in the control group will only have access to the self-monitoring section. One, three, and six months after surgery, she will complete other assessment scales during her outpatient follow-up. Scales will be sent online for patients providing remote control. After the project is completed, all content will be opened to the control group patients.
Study NCT06080815 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CAD/CAM Complete denture
Description: four implant-supported CAD/CAM complete overdenture
Study NCT05435521 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Body composition
Description: Analyze the effects of PMEP on body composition in each evaluation using an impedance threshold device
Study NCT05435521 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Body composition
Description: Analyze the effects of PMEP on body composition in each evaluation using an impedance threshold device
Study NCT05435521 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Musculoskeletal and visceral Ultrasound
Description: Quadriceps muscle ultrasound (US) of the rectus femoris measured in each evaluation in order to analyze the effects of PMEP Visceral fat will be analyzed in each visit
Study NCT04607551 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Prone positionning
Description: 4 to 5 persons required for the procedure, one of them being dedicated to the management of the head of the patient, the endotracheal tube, the jugular ECMO cannula and the ventilator lines and another dedicated to the femoral ECMO cannula. The person at the head of the bed will coordinate the steps. The other persons will stand at each side of the bed. The direction of the rotation will be decided giving priority to the side of the central venous lines. The length of vascular and ventilator lines will be checked for appropriateness, the endotracheal tube and gastric tube will be secured, and the patient's knees, forehead, chest, and iliac crests will be protected using adhesive pads. The patient will be then moved along the horizontal plane to the opposite side of the bed selected for the direction of rotation. Patients will be proned at least four times during the first days on ECMO. Each prone session will stand for at least 16 hours
Study NCT04607551 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Supine position
Description: Patients assigned to supine will remain in a semi-recumbent position.
Study NCT05435521 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Musculoskeletal and visceral Ultrasound
Description: Quadriceps muscle ultrasound (US) of the rectus femoris measured in each evaluation in order to analyze the effects of PMEP Visceral fat will be analyzed in each visit
Study NCT05189899 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Virtual reality
Description: One hemodialysis session with virtual reality and one other without it
Study NCT05863949 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: vitamin D +/- calcium
Description: vitamin D 1000iU daily +/- calcium 500mg BID daily
Study NCT05863949 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo pill x3 daily
Study NCT06397482 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Encapsulated Calcium Butyrate
Description: Contains at minimum 35% butyric acid
Study NCT05648721 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Datos mobile health application
Description: The mobile Health application will send women reminders to perform glucose tests and test results will be sent to the clinic personnel for evaluation. The clinic personnel will receive an alert if a woman does not send glucose charts or when there is an abnormality in the test results. In addition, women will be able to communicate with the clinic's personnel via chat, messages, phone calls, and video.
Study NCT05648721 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Regular follow-up
Description: Regular follow-up according to the local clinic protocol
Study NCT05827120 — intervention group
Intervention type: DEVICE
Intervention: Mechanical / pharmacomechanical thrombectomy plus local catheter directed thrombolysis
Description: * Catheter directed thrombolysis (CDT): dedicated thrombolytic catheter with side holes is placed across the acute thrombus, and slow, continuous infusion (through the catheter, or both through the catheter and sheath) of a chemical thrombolysis agent is applied - alteplase 1mg/hour plus unfractionated heparine in anticoagulation dosage;~* Mechanical thrombectomy: mechanical aspiration of fresh thrombus;~* Pharmacomechanical thrombectomy (PMT): combination of mechanical disruption of the thrombus, and its aspiration, with simultaneous application of alteplase via dedicated catheter - instilation of acute/subacute thrombus with its subsequent aspiration;
Study NCT05827120 — intervention group
Intervention type: DEVICE
Intervention: Local catheter directed thrombolysis alone
Description: - Catheter directed thrombolysis (CDT): dedicated thrombolytic catheter with side holes is placed across the acute thrombus, and slow, continuous infusion (through the catheter, or both through the catheter and sheath) of a chemical thrombolysis agent is applied - alteplase 1mg/hour plus unfractionated heparine in anticoagulation dosage;
Study NCT05031130 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Empowered program integrated with family support
Description: The empowered program integrated with family support is an intervention consisted of five steps that will be given when pregnant adolescents on gestational age 32 or 33 weeks the second meeting will be when the pregnant adolescents on gestational age 34 or 35 weeks.
Study NCT05951686 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Desflurane
Description: In inhalation group, desflurane will be used for general anesthesia maintenance under the screening with Patient State Index (PSI) between a score of 25-50. Remifentanil infusion is used with desflurane with a dose of 0.05-2 mcg/ kg/ min according to PSI . Fresh gas flow is used 2 L/ min with a mixture of 50%- 50% oxygen and medical air in both groups.
Study NCT05951686 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Remifentanil infusion
Description: Remifentanil infusion will be used with a dose of 0.05-2 mcg/ kg/ min under the screening with Patient State Index (PSI) between a score of 25-50 in both groups.
Study NCT05951686 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Fresh gas
Description: Fresh gas flow will be used 2 L/ min with a mixture of 50%- 50% oxygen and medical air in both groups.
Study NCT05951686 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol infusion
Description: Propofol infusion will be used for general anesthesia maintenance with a dose of under the screening of Patient State Index (PSI) between a score of 25-50 in group tiva.
Study NCT05604300 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin E incorporated oat supplement
Description: A twice daily supplementation of Vitamin E incorporated oat for 12 weeks
Study NCT05604300 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Oat supplement
Description: A twice daily supplementation of oat for 12 weeks
Study NCT05836090 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Spirit Strengths (FSS)
Description: The FSS intervention consists of psychoeducational components that emphasize the importance of mental and emotional health as part of overall wellness, and seek to normalize experiences of stress, to de-stigmatize help-seeking, and to build hope. Core content focuses on awareness of the connections between thoughts, feelings, behaviors, and spirituality, and imparts related self-help skills. It also specifically builds in connection to culture, land and others as coping strategies. The FSS lessons were developed based on culturally adapting the Common Elements Treatment Approach (CETA).
Study NCT05836090 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Family Spirit Nurture
Description: The active control Family Spirit Nurture, is an evidence-based nutrition education curriculum that has been previously tested with Navajo communities which focuses on age-appropriate parental feeding practices, including snack routines, avoidance of sugar-sweetened beverages (SSB) and promotion of water consumption.
Study NCT05760495 — intervention group
Intervention type: OTHER
Intervention: blood sampling
Description: Blood sampling for evaluation of oxidative stress markers
Study NCT05925621 — intervention group
Intervention type: DRUG
Intervention: Lecanemab
Description: Observational study
Study NCT05381688 — intervention group
Intervention type: PROCEDURE
Intervention: VIM DBS
Description: Stereotactic deep brain stimulation of ventral intermediate nucleus of thalamus
Study NCT05672264 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Whole-Body Electromyostimulation
Description: Consistently supervised, video-guided WB-EMS application 1.5 times per week for 28 weeks. Bipolar electric current with a frequency of 85Hz, an impulse-width of 350 µs will be used in an interval approach with 6 sec of EMS stimulation with a direct impulse boost and 4 sec of rest. Low intensity movements or exercises in a standing position were performed during the 6 s stimulation period.
Study NCT05672264 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physiotherapy
Description: Six standardised physiotherapy sessions (20 min each)
Study NCT04865653 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lysergic Acid Diethylamide Base oral drinking solution
Description: A moderate dose of 0.1 mg LSD will be administered.
Study NCT04865653 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lysergic Acid Diethylamide Base solid orodispersible film
Description: A moderate dose of 0.1 mg LSD will be administered.
Study NCT04865653 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lysergic Acid Diethylamide Tartrate oral drinking solution
Description: A moderate dose of 0.146 mg LSD tartrate will be administered (equivalent to 0.1 mg LSD base).
Study NCT04865653 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lysergic Acid Diethylamide Tartrate intravenous administration
Description: A moderate dose of 0.146 mg LSD tartrate will be administered (equivalent to 0.1 mg LSD base).
Study NCT04865653 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: LSD Placebo
Description: Placebo for each formulation containing only the solvent or gel but no LSD.
Study NCT05206318 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topical Cysteamine
Description: Topical cysteamine cream applied to the postinflammatory hyperpigmentation dark spots 15 minutes per day, followed by a face wash and moisturizing cream.
Study NCT05206318 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Topical Vehicle Control
Description: Topical vehicle control cream without cysteamine active ingredients applied to the postinflammatory hyperpigmentation dark spots 15 minutes per day, followed by a face wash and moisturizing cream.
Study NCT05307744 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: PS128
Description: Each PS128 capsule contained >3 × 10\^10 colony forming units (CFU) with microcrystalline cellulose and weights 425 ± 25 mg.
Study NCT05307744 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo capsules only contained 425 ± 25 mg microcrystalline cellulose.
Study NCT06286722 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Progressive, individualized and structured exercise program
Description: See description under Arms
Study NCT06559436 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravenous thrombolysis
Description: Patients in the TNK treatment group will receive TNK intravenous thrombolysis after MeVO is determined, and the usual dosage for TNK intravenous thrombolysis is 0.25mg/Kg, with a maximum of 25mg,
Study NCT06559436 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard medical management
Description: Standard medical management
Study NCT05091138 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Adding Magnesium as an adjuvant to Bupivacaine in the adductor canal block (ACB) for same-day discharge total knee arthroplasty
Description: Post-operatively all patients will have an ultrasound-guided adductor canal block (ACB) with 30cc of 0.25% bupivacaine. Half of the patients (selected randomly using random number table) will receive 150mg of magnesium sulfate in the block and the other half will receive 300 mcg of buprenorphine in the block.
Study NCT05091138 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Adding Buprenorphine as an adjuvant to Bupivacaine in the adductor canal block (ACB) for same-day discharge total knee arthroplasty
Description: Post-operatively all patients will have an ultrasound-guided adductor canal block (ACB) with 30cc of 0.25% bupivacaine. Half of the patients (selected randomly using random number table) will receive 150mg of magnesium sulfate in the block and the other half will receive 300 mcg of buprenorphine in the block.
Study NCT06333964 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AST-001
Description: AST-001, PO bid for 24weeks (dosage according to weight range)
Study NCT06333964 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo of AST-001
Description: Placebo of AST-001, PO bid for 12 weeks + AST-001, PO bid for 12 weeks (dosage according to weight range)
Study NCT04991584 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amoxicillin,Tetracycline,Furazolidone,Levofloxacin,Vonoprazan fumarate, Esomeprazole ,
Description: Patients will go through a gastroscopy and antimicrobial susceptibility test. Liver and kidney function will be monitored by blood test before and after the treatment.
Study NCT05526768 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: VITLS Device
Description: VITLS remote vital sign monitoring device will be applied to consented patients so data obtained by the device can be compared to data obtained by traditional inpatient hospital monitoring devices.
Study NCT04558827 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low Carbohydrate Diet
Description: Dietary choices are counseled to come primarily from lean meats, eggs, nuts, seeds, vegetables and berries.
Study NCT04558827 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Time Restricted Feeding
Description: Participants will be asked to have 2 meals within an 8 hour period, preferably before 2pm.
Study NCT05125497 — intervention group
Intervention type: PROCEDURE
Intervention: In Vitro Fertilisation (IVF)
Description: Natural Cycle In Vitro Fertilisation (IVF): without hormonal stimulation Conventional In Vitro Fertilisation (IVF): conventional hormonal stimulation Minimal Stimulation In Vitro Fertilisation (IVF): low dose of hormonal stimulation will be applied
Study NCT05256264 — intervention group
Intervention type: DRUG
Intervention: Ketamine
Description: Ketamine infusion at different dose to observe EEG DSA changes
Study NCT05384301 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Urban Afforestation Program
Description: An afforestation program based on land cultivation and transplantation of several plants for 90 minutes will be implemented.
Study NCT05010967 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High intensity interval training
Description: HIIT 3 times a week for 8 weeks. For week 1 to 4 , Warm up 5 minutes jogging in place, 6 series of 30 seconds Burpees, 30 seconds recovery, 30 seconds skipping, 30 seconds recovery, 30 seconds lunge, 30 seconds recovery, 30 seconds 1-legged squats, 30 seconds recovery, 30 second leg levers, 30 seconds recovery. the series will have 3 minutes rest in between. Cool down of 10 minutes with gentle stretches.~For week 5 to 8 , Warm up 5 minutes jogging in place, 6 series of 45 seconds Burpees, 45 seconds recovery, 45 seconds skipping, 30 seconds recovery, 45 seconds lunge, 30 seconds recovery, 45 seconds 1-legged squats, 30 seconds recovery, 45 second leg levers, 30 seconds recovery. the series will have 3 minutes rest in between. Cool down of 10 minutes with gentle stretches.
Study NCT05010967 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Yoga Training
Description: Yoga 3 times a week for 8 weeks. 30-50 minutes session, 5 minutes breathing, 15-35 minutes yoga poses (Cat-cow, child's pose, downward dog, plank, Cobra), followed by 10 minutes supine meditation.
Study NCT06393959 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Caudal epidural pulsed radiofrequency
Description: The patient lied in prone position. After cutaneous and subcutaneous anesthesia with 3 ml of 2% lidocaine, a 22- gauge 150-mm RF cannula with 20 mm active tip was advanced through the sacrococcygeal ligament into the caudal epidural space under floroscopic guidence. A few milliliters contrast was injected to observe the expansion of the epidural space. After correct needle placement was confirmed, an electrode was connected to the cannula, and stimulation was conducted with impedance measured between 250 and 350 Ohms A different sensation or feeling such as fullness, impression, tingling, pulling or plethora at the rectal and/or coccygeal region was observed by the patients when 50 Hz was applied with 0,4 to 0,7 V sensory stimulation. No leg muscle contraction was observed with 2 Hz motor stimulation at 2 V. PRF was performed for 600 s at 5 Hz using a 5-ms pulse width at 55 V, avoiding electrode tip temperatures above 42 C.
Study NCT06393959 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Caudal epidural steroid enjection
Description: The patient lied in prone position and aseptic techniques were adopted. After cutaneous and subcutaneous anesthesia with 3 ml of 2% lidocaine, a spinal needle was advanced through the sacrococcygeal ligament into the caudal epidural space under fluoroscopic guidance. The needle tip was confirmed by negative aspiration for blood or cerebrospinal fluid, then a few milliliters of contrast was injected to observe the expansion of the epidural space. After correct needle placement was confirmed, a total of 10 ml mixture of saline and 8 mg dexametzone was administered into the epidural space.
Study NCT06064331 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lignocaine
Description: IV bolus of 1.5 mg/kg of lignocaine 2% diluted in 10 ml syringe over 3 mins followed by infusion at 1 mg/kg/h of lignocaine 2% in 20 ml syringe
Study NCT06064331 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: IV bolus of 10 ml normal saline over 3 min followed by infusion of equal volume of normal saline in 20 ml syringe
Study NCT04800315 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CC-93538
Description: Specified dosages on specified days
Study NCT04800315 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Specified dosages on specified days